Long intergenic non-protein coding RNA 2455 (LINC02455)

Long intergenic non-protein coding RNA 2455 (LINC02455) is a member of the long intergenic non-coding RNA (lincRNA) family, defined as autonomously transcribed RNA molecules longer than 200 nucleotides that do not encode proteins and do not overlap with known protein-coding genes[1][3]. LINC02455 is annotated at the RNA level and is likely involved in the regulation of gene expression or chromatin state, similar to other lincRNAs, although no specific molecular functions, disease associations, or drug targeting activities have been reported for this transcript to date[1][3]. The biological roles of the majority of lincRNAs, including LINC02455, remain unclear, but generally, they participate in processes such as chromatin remodeling, transcriptional regulation, and potentially modulation of neighboring genes, while exhibiting significant tissue specificity[3][5]. Clarification and limitations: - There is no evidence that LINC02455 functions as a "target" in the conventional therapeutic sense (such as a receptor, enzyme, or established drug target)[1][3]. - No aliases, disease associations, biomarkers, or drug interactions are documented for LINC02455 in authoritative transcriptome and gene annotation resources as of now[1]. - Biological and clinical information are inferred from the general lincRNA family context, as direct functional data for LINC02455 is lacking. If further details become available in future genome or transcript annotation updates, these fields could be further refined.